CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-27 | England Kristin Chief Administrative Officer | Grant or award | +55,743 | 153,780 | ||
| 2026-03-27 | Podnos Yale Chief Medical Officer | Grant or award | +66,446 | 300,956 | ||
| 2026-03-27 | Podnos Yale Chief Medical Officer | Other disposition | −16,173 | $3.07 | $50K | 284,783 |
| 2026-03-27 | Carter Robert Ross Chief Financial Officer | Grant or award | −202,914 | 436,725 | ||
| 2026-03-27 | Carter Robert Ross Chief Financial Officer | Other disposition | −20,320 | $3.07 | $62K | 416,405 |
| 2026-03-27 | Virnich Daniel Chief Executive Officer | Grant or award | −670,608 | 2,458,758 | ||
| 2026-03-27 | Virnich Daniel Chief Executive Officer | Other disposition | −98,534 | $3.07 | $302K | 2,360,224 |
| 2026-03-27 | Chernett Jorey 10% owner | Purchase | +27,429 | $2.96 | $81K | 10,479,358 |
| 2026-03-26 | Chernett Jorey 10% owner | Purchase | +50,000 | $3.15 | $158K | 10,451,929 |
| 2026-03-24 | Chernett Jorey 10% owner | Purchase | +125,000 | $3.11 | $389K | 10,401,929 |
| 2026-03-20 | Chernett Jorey 10% owner | Purchase | +25,000 | $3.35 | $84K | 10,276,929 |
| 2026-03-17 | Virnich Daniel Chief Executive Officer | Other disposition | −11,834 | $3.59 | $42K | 1,788,150 |
| 2026-03-17 | Carter Robert Ross Chief Financial Officer | Other disposition | −1,314 | $3.59 | $5K | 233,811 |
| 2026-03-17 | Podnos Yale Chief Medical Officer | Other disposition | −3,420 | $3.59 | $12K | 234,510 |
| 2026-03-17 | Chernett Jorey 10% owner | Purchase | +75,000 | $3.42 | $257K | 10,251,929 |
| 2026-03-16 | Chernett Jorey 10% owner | Purchase | +60,985 | $3.29 | $201K | 10,176,929 |
| 2026-03-13 | Chernett Jorey 10% owner | Purchase | +263,000 | $2.92 | $768K | 10,115,944 |
| 2026-01-02 | Carter Robert Ross Chief Financial Officer | Other disposition | −244 | $3.67 | $895 | 235,125 |
| 2026-01-02 | Carter Robert Ross Chief Financial Officer | Sale | −247 | $3.56 | $879 | 235,122 |
| 2025-12-15 | Hively Brad Director | Sale | −13,333 | $3.77 | $50K | 683,721 |
Page 3 of 8 · 157 trades